These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29412113)

  • 1. Screening for Rare Genetic Variants Associated with Atherosclerosis: Opportunity for Personalized Medicine.
    Peterlin A; Petrovič D; Peterlin B
    Curr Vasc Pharmacol; 2019; 17(1):25-28. PubMed ID: 29412113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Lipidology and the Prevention of Vascular Disease: Time for Personalized Therapy.
    Brown WV
    Clin Pharmacol Ther; 2018 Aug; 104(2):269-281. PubMed ID: 29998536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Drugs and Genetic Factors on the Development and Progression of the Atherosclerotic Process.
    Šabovič M; Petrovič D
    Curr Vasc Pharmacol; 2019; 17(1):3-5. PubMed ID: 30474522
    [No Abstract]   [Full Text] [Related]  

  • 4. Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use?
    Paynter NP; Ridker PM; Chasman DI
    Circ Res; 2016 Feb; 118(4):607-19. PubMed ID: 26892961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using genetics to guide treatment and drug development in cardiovascular medicine: time to reveal the proof in the pudding.
    Nicholls SJ
    Cardiovasc Res; 2020 Feb; 116(2):e30-e32. PubMed ID: 31845983
    [No Abstract]   [Full Text] [Related]  

  • 6. High-Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic-Driven Medicine.
    Ipe J; Swart M; Burgess KS; Skaar TC
    Clin Transl Sci; 2017 Mar; 10(2):67-77. PubMed ID: 28213901
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focus on different lipid-lowering treatment and genetic testing for optimal pharmacotherapy use in the clinic.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2024 Oct; 10(6):479-480. PubMed ID: 39364572
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical applications of next-generation sequencing in colorectal cancers.
    Kim TM; Lee SH; Chung YJ
    World J Gastroenterol; 2013 Oct; 19(40):6784-93. PubMed ID: 24187453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia.
    Hegele RA; Dron JS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1970-1981. PubMed ID: 32762461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant discovery in patients with Mendelian vascular anomalies by next-generation sequencing and their use in patient clinical management.
    Mattassi R; Manara E; Colombo PG; Manara S; Porcella A; Bruno G; Bruson A; Bertelli M
    J Vasc Surg; 2018 Mar; 67(3):922-932.e11. PubMed ID: 28655553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of genetic testing in dyslipidaemia.
    Berberich AJ; Hegele RA
    Pathology; 2019 Feb; 51(2):184-192. PubMed ID: 30558903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can genetic testing help in the management of dyslipidaemias?
    Lazarte J; Hegele RA
    Curr Opin Lipidol; 2020 Aug; 31(4):187-193. PubMed ID: 32520779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
    Wilson BJ; Miller FA; Rousseau F
    J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine in chronic kidney disease by detection of monogenic mutations.
    Connaughton DM; Hildebrandt F
    Nephrol Dial Transplant; 2020 Mar; 35(3):390-397. PubMed ID: 30809662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted next-generation sequencing in monogenic dyslipidemias.
    Hegele RA; Ban MR; Cao H; McIntyre AD; Robinson JF; Wang J
    Curr Opin Lipidol; 2015 Apr; 26(2):103-13. PubMed ID: 25692347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy.
    Marmontel O; Charrière S; Simonet T; Bonnet V; Dumont S; Mahl M; Jacobs C; Nony S; Chabane K; Bozon D; Janin A; Peretti N; Lachaux A; Bardel C; Millat G; Moulin P; Marçais C; Di Filippo M
    Clin Genet; 2018 Jul; 94(1):132-140. PubMed ID: 29572815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.
    Musunuru K; Kathiresan S
    Circ Res; 2016 Feb; 118(4):579-85. PubMed ID: 26892959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene and Variant Annotation for Mendelian Disorders in the Era of Advanced Sequencing Technologies.
    Chakravorty S; Hegde M
    Annu Rev Genomics Hum Genet; 2017 Aug; 18():229-256. PubMed ID: 28415856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
    Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
    Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.